alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                           AND CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying Quarterly Report On Form 10-QSB of Edmonds
3, Inc. for the quarter ending January 31, 2005, I, Richard Neussler, Chief
Executive Officer and Chief Financial Officer of Edmonds 3, Inc. hereby certify
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:

     1.   Such Quarterly Report on Form 10-QSB for the quarter ending January
          31, 2005, fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     2.   The information contained in such Quarterly Report on Form 10-QSB for
          the quarter ending January 31, 2005, fairly presents, in all material
          respects, the financial condition and results of operations of
          Edmonds 3, Inc.

Dated:  March 17, 2005

EDMONDS 3, INC.

By: /s/ Richard Neussler
-------------------------------------
Chief Executive Officer and
Chief Financial Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Exploratory Centers (P20) for Benign Urology.                    

*Date:*                         July 20, 2021.                    

*Time:*                         1:00 p.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Lan Tian, Ph.D., Scientific Review Officer, National Institute of Diabetes and Digestive and Kidney Diseases, National                               ( print page 29592)                            Institutes of Health, Bethesda, MD 20892-5452, 202-821-7210 (mobile), email:                         *tianl@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: May 26, 2021. 

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-11515 Filed 6-1-21; 8:45 am]

BILLING CODE 4140-01-P
**EXHIBIT 32.1**

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Paul A. Parisotto, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Blacksands Petroleum, Inc., for the fiscal quarter ended July 31, 2008 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Blacksands Petroleum, Inc.

 

 

| Date:    September 15, 2008 | By:    /s/ Paul A. Parisotto                                                                   |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                  |           Paul A. Parisotto, Principal Executive Officer                                                                                                                                                                                                                                                                                                                                         |
|                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                    |  |  |

 

 

 

----
Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. Section 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Lucas Energy, Inc. on Form 10-Q for the nine months ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William A. Sawyer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/William A. SawyerWilliam A. SawyerChief Executive OfficerFebruary 12, 2009


---
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

May 7, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-7076

United Scope LLC: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/Notice_of_Product_Exclusions

_05.09.19.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

May 7, 2019

RE: Product Exclusion Request Number USTR-2018-0025-7456

Carestream Health, Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request concerns a product strategically important or related to 

“Made in China 2025” or other Chinese industrial programs.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 19, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-6445

DENSO International America, Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that this particular product is available 

only from China.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<EXCHANGE-RATE>                                      1
<CASH>                                              49
<SECURITIES>                                         0
<RECEIVABLES>                                      114
<ALLOWANCES>                                         3
<INVENTORY>                                        122
<CURRENT-ASSETS>                                   314
<PP&E>                                           1,173
<DEPRECIATION>                                     717
<TOTAL-ASSETS>                                     873
<CURRENT-LIABILITIES>                              314
<BONDS>                                            137<F1>
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             3<F2>
<OTHER-SE>                                         221
<TOTAL-LIABILITY-AND-EQUITY>                       873
<SALES>                                          1,250
<TOTAL-REVENUES>                                 1,250
<CGS>                                            1,134
<TOTAL-COSTS>                                    1,198
<OTHER-EXPENSES>                                     6<F3>
<LOSS-PROVISION>                                   (1)
<INTEREST-EXPENSE>                                  12
<INCOME-PRETAX>                                     35
<INCOME-TAX>                                        12
<INCOME-CONTINUING>                                 23
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        23
<EPS-PRIMARY>                                     0.98
<EPS-DILUTED>                                     0.95
<FN>
<F1>Total long-term debt
<F2>Does not include additional-paid-in capital
<F3>Includes other expense and interest income
</FN>
        

</TABLE>
[Federal Register Volume 60, Number 71 (Thursday, April 13, 1995)]
[Notices]
[Page 18857]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9115]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Notice Pursuant to the National Research and Production Act of 
1993--Collaboration for Development of a Manufacturing Competency for 
High Performance Composites

    Notice is hereby given that, on February 23, 1995, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), E.I. du Pont de Nemours and 
Company (``E.I. du Pont'') have filed written notifications 
simultaneously with the Federal Trade Commission disclosing (1) the 
identities of the parties and (2) the nature of objectives of a 
cooperative arrangement known as the ``Collaboration for Development of 
a Manufacturing Competency for High Performance Composites for Civil 
Infrastructure Applications.'' The notifications were filed for the 
purpose of invoking the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances. 
Pursuant to Section 6(b) of the Act, the identities of the parties are: 
E.I. du Pont, Newark, DE; Hardcore Du Pont Composites L.L.C., New 
Castle, DE; The Dow Chemical Company, Freeport, TX; Brunswick 
Technologies, Inc., Brunswick, ME; and Johns Hopkins University, 
Baltimore, MD. The purpose of the cooperative arrangement is to develop 
a manufacturing competency for large composite structures based on 
resin infusion technology focusing on commercial applications for the 
civil infrastructure market. The program resulted from an award by the 
National Institute of Standards and Technology, United States 
Department of Commerce.
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 95-9115 Filed 4-12-95; 8:45 am]
BILLING CODE 4410-01-M
[Federal Register Volume 60, Number 72 (Friday, April 14, 1995)]
[Notices]
[Page 19109]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9300]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Office of the Secretary


Notice of Call for Redemption

Washington, April 11, 1995.
    To Holders of 8\3/8\ Percent Treasury Bonds of 1995-00, and Others 
Concerned:
    1. Public notice is hereby given that all outstanding 8\3/8\ 
percent Treasury Bonds of 1995-00 (CUSIP No. 912810 BV 9) dated August 
15, 1975, due August 15, 2000, are hereby called for redemption at par 
on August 15, 1995, on which date interest on such bonds will cease.
    2. Full information regarding the presentation and surrender of 
such bonds held in coupon and registered form for redemption under this 
call will be found in Department of the Treasury Circular No. 300, 
Revised, dated March 4, 1973, and by contacting a Federal Reserve Bank 
or Branch.
    3. Such bonds held in book-entry form will be paid automatically on 
August 15, 1995, whether held on the books of the Federal Reserve Banks 
or in TREASURY DIRECT accounts.
Gerald Murphy,
Fiscal Assistant Secretary.
[FR Doc. 95-9300 Filed 4-11-95; 4:07 pm]
BILLING CODE 4810-40-M
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 26, 2019

RE: Product Exclusion Request Number USTR-2018-0025-6678

Invacare Corp:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel
Exhibit 21.1



SUBSIDIARIES OF GATEWAY, INC.



|                                                      |  |               
|----------------------------------------------------- |  | --------------
|Name of Entity                                        |  | Jurisdiction  
|AD Technologies, LLC                                  |  | Delaware      
|eMachines Internet Group, Inc.                        |  | Delaware      
|Gateway 2000 Asia Pte., Ltd.                          |  | Singapore     
|Gateway Canada Corp.                                  |  | Canada        
|Gateway Companies, Inc.                               |  | Delaware      
|Gateway Computers Ireland Limited                     |  | Ireland       
|Gateway Direct, Inc.                                  |  | Delaware      
|Gateway Europe, B.V.                                  |  | Netherlands   
|Gateway France, SAS                                   |  | France        
|Gateway International Computers, Ltd.                 |  | Ireland       
|Gateway International Holdings, Inc.                  |  | Delaware      
|Gateway KK                                            |  | Japan         
|Gateway Malaysia SDN BHD                              |  | Malaysia      
|Gateway Manufacturing, LLC                            |  | Delaware      
|Gateway New Zealand Ltd.                              |  | New Zealand   
|Gateway Pro Partners, LLC (less than wholly owned)    |  | Delaware      
|Gateway Professional, LLC                             |  | Delaware      
|Gateway Singapore Pte Ltd.                            |  | Singapore     
|Gateway Spain, S.L.                                   |  | Spain         
|Gateway Sub II, LLC                                   |  | Delaware      
|Gateway Technologies, Inc.                            |  | Delaware      
|Gateway US Retail, Inc.                               |  | Delaware      
|Gateway, Ltd.                                         |  | United Kingdom
|GTW de Mexico, S. de R.L. de C.V.                     |  | Mexico        
|Nicolas Insurance Company, Ltd.                       |  | Bermuda       
|Servicios Profesionales de Acceso, S. de R.L. de C.V. |  | Mexico
<PAGE>

                                                                    Exhibit 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Metretek Technologies, Inc.
(the "Company") on Form 10-K for the fiscal year ended December 31, 2003 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, W. Phillip Marcum, President and Chief Executive Officer of the
Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         1.       The Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934, as
                  amended; and

         2.       The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Company.

Date: March 30, 2004                     /s/  W. Phillip Marcum
                                         -----------------------------------
                                         W. Phillip Marcum
                                         President and Chief Executive Officer

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.